论文部分内容阅读
目的分析硝普钠联合参附注射液治疗慢性心衰的临床疗效。方法选取在本院接受治疗的慢性心力衰竭患者50例作为研究对象,随机分为两组,对照组给予常规西药治疗,治疗组在对照组基础上使用硝普钠静脉泵入以及联合参附注射液静脉滴注治疗,比较两组患者治疗前后的心率、收缩压、舒张压、平均动脉压、心胸比率、左室舒张末直径(LVD)、左室射血分数(LVEF)、左室短轴缩短率(LVFS)和患者血液动力学相关指标及治疗有效率。结果患者在使用硝普钠联合参附注射液治疗后,其心率、收缩压、舒张压、平均动脉压、心胸比率、左室舒张末直径(LVD)、左室射血分数(LVEF)、左室短轴缩短率(LVFS)和患者血液动力学相关指标均优于单纯使用常规西药治疗(P<0.05),治疗有效率达96.00%。结论硝普钠联合参附注射液治疗慢性心衰,能显著提高患者的临床疗效。
Objective To analyze the curative effect of sodium nitroprusside and Shenfu injection on chronic heart failure. Methods 50 cases of chronic heart failure patients treated in our hospital were selected as study subjects and randomly divided into two groups. The control group was given conventional western medicine. The treatment group received intravenous injection of sodium nitroprusside and the combination of Shenfu injection Intravenous infusion therapy was used to compare heart rate, systolic blood pressure, diastolic blood pressure, mean arterial pressure, cardiothoracic rate, left ventricular end diastolic diameter (LVD), left ventricular ejection fraction (LVEF), left ventricular short axis Shortening rate (LVFS) and hemodynamic parameters of patients and treatment efficiency. Results After treatment with sodium nitroprusside and Shenfu injection, the heart rate, systolic blood pressure, diastolic blood pressure, mean arterial pressure, cardiothoracic ratio, left ventricular end diastolic diameter (LVD), left ventricular ejection fraction (LVEF) The LVFS and the hemodynamics of patients were better than those of the conventional western medicine alone (P <0.05), and the effective rate was 96.00%. Conclusion Sodium nitroprusside combined with Shenfu injection in the treatment of chronic heart failure can significantly improve the clinical efficacy of patients.